INTERVIEW WITH ROGER HAYES
new workflows. It does work, it’s routine. There’s nothing to be scared about. There’s no need for conservatism. It works.
It is an exciting time to be doing bioanalysis, in 20 years going from 0.5 ml to now thinking of 2 µl as routine that’s exciting. I’d like to see what the next 10 years looks like, it’s almost unimaginable to think that we’ve dropped multiple logs in volume and the sensitivity has enhanced greatly; picagrams have become routine and we used to think micrograms was tough, so it is an exciting time!
More about Roger Hayes 20
Roger Hayes, PhD, is Senior Vice President, DMPK, at MPI Research (Mattawan, MI, USA). Dr Hayes has held numerous leadership positions in the global life sciences industry and academia, leading teams in the development of state-of-the-art bioanalytical and analytical techniques, including mass spectrometry, chromatography, and automation in bringing medical and chemical products to market. For nearly two decades, he has led strategic and research initiatives for large pharmaceutical companies that included both GLP and non-GLP preclinical studies as well as clinical trials. Most recently, he served as President of
Bioanalytical Operations, at Cetero Research (ND, USA) where he focused on establishing overall corporate direction for bioanalytical and analytical services. Dr Hayes has published extensively and has taught numerous aspects of LC/MS method development. He is an active member of the American Society for Mass Spectrometry and the American Association of Pharmaceutical Scientists.
www.bioanalysis-zone.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48
